on 24 Oct 2023
Last Applicant/ Owned by
10578 Science Drive, Suite 125
San Diego
CA
92121
Serial Number
97087685 filed on 22nd Oct 2021
Registration Number
7202824 registered on 24th Oct 2023
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
Oligonucleotide-conjugate based therapies, oligonucleotide-antibody conjugate based therapies, and oligonucleotide-antibody fragment conjugate based therapies for the treatment of metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, neuromuscular, rare muscle diseases, cardiomyopathies, heart muscle diseases, muscular dystrophies, muscle atrophy, genitourinary, oncological, hepa Read More
Oligonucleotide-conjugate based therapies, oligonucleotide-antibody conjugate based therapies, and oligonucleotide-antibody fragment conjugate based therapies for the treatment of metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, neuromuscular, rare muscle diseases, cardiomyopathies, heart muscle diseases, muscular dystrophies, muscle atrophy, genitourinary, oncological, hepatological, ophthalmic, respiratory, central and/or peripheral neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders
02th Aug 2021
02th Aug 2021
No 97087685
No Service/Collective Mark
No 45532-TM1007
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
24th Oct 2023 | REGISTERED-PRINCIPAL REGISTER |
24th Oct 2023 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
22nd Sep 2023 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
21st Sep 2023 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
20th Aug 2023 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
20th Aug 2023 | STATEMENT OF USE PROCESSING COMPLETE |
10th Aug 2023 | TEAS STATEMENT OF USE RECEIVED |
10th Aug 2023 | USE AMENDMENT FILED |
08th Aug 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
04th Aug 2023 | SOU TEAS EXTENSION RECEIVED |